NewsBenzingaLifecore生物医学将被韦伯斯特股本合伙人以高达6.637亿美元的交易收购；股东可能在完全履行里程碑付款时获得每普通等值股票高达9.67美元的现金和CVR的综合报酬 Lifecore生物医学将被韦伯斯特股本合伙人以高达6.637亿美元的交易收购；股东可能在完全履行里程碑付款时获得每普通等值股票高达9.67美元的现金和CVR的综合报酬 Benzinga 2026.09.28 12:46 (GMT+0) Open on Benzinga Other news BofA: US memory stock valuations show signs of cycle bottom, market concerns overblown BCX: Invest In Essential Resources, Collect 7% Monthly Income (NYSE:BCX) Tech stocks stumbled. Now comes a crucial week for Wall Street. UnitedHealth: My Thesis Has Played Out, I Wouldn't Chase Here (NYSE:UNH) OFG Bancorp: Risks Remain, But Not Enough To Prevent An Upgrade (NYSE:OFG) Vaxcyte: Vaccine Titan In The Making (NASDAQ:PCVX)
